Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 26

1.

Soluble fas and the -670 polymorphism of fas in lupus nephritis.

Bollain-Y-Goytia JJ, Arellano-Rodríguez M, Torres-Del-Muro Fde J, Daza-Benítez L, Muñoz-Valle JF, Avalos-Díaz E, Herrera-Esparza R.

Int J Nephrol. 2014;2014:780406. doi: 10.1155/2014/780406. Epub 2014 Nov 18.

2.

FAS system deregulation in T-cell lymphoblastic lymphoma.

Villa-Morales M, Cobos MA, González-Gugel E, Álvarez-Iglesias V, Martínez B, Piris MA, Carracedo A, Benítez J, Fernández-Piqueras J.

Cell Death Dis. 2014 Mar 6;5:e1110. doi: 10.1038/cddis.2014.83.

3.

Precise mapping of the CD95 pre-ligand assembly domain.

Edmond V, Ghali B, Penna A, Taupin JL, Daburon S, Moreau JF, Legembre P.

PLoS One. 2012;7(9):e46236. doi: 10.1371/journal.pone.0046236. Epub 2012 Sep 25.

4.

Autoimmune lymphoproliferative syndrome: response to mycophenolate mofetil and pyrimethamine/sulfadoxine in a 5-year-old child.

Arora S, Singh N, Chaudhary GK, John MJ.

Indian J Hematol Blood Transfus. 2011 Jun;27(2):101-3. doi: 10.1007/s12288-011-0058-2. Epub 2011 Apr 16.

5.

FAS haploinsufficiency is a common disease mechanism in the human autoimmune lymphoproliferative syndrome.

Kuehn HS, Caminha I, Niemela JE, Rao VK, Davis J, Fleisher TA, Oliveira JB.

J Immunol. 2011 May 15;186(10):6035-43. doi: 10.4049/jimmunol.1100021. Epub 2011 Apr 13.

6.

Onset of autoimmune lymphoproliferative syndrome (ALPS) in humans as a consequence of genetic defect accumulation.

Magerus-Chatinet A, Neven B, Stolzenberg MC, Daussy C, Arkwright PD, Lanzarotti N, Schaffner C, Cluet-Dennetiere S, Haerynck F, Michel G, Bole-Feysot C, Zarhrate M, Radford-Weiss I, Romana SP, Picard C, Fischer A, Rieux-Laucat F.

J Clin Invest. 2011 Jan;121(1):106-12. doi: 10.1172/JCI43752. Epub 2010 Dec 22.

7.

The Fas-FADD death domain complex structure reveals the basis of DISC assembly and disease mutations.

Wang L, Yang JK, Kabaleeswaran V, Rice AJ, Cruz AC, Park AY, Yin Q, Damko E, Jang SB, Raunser S, Robinson CV, Siegel RM, Walz T, Wu H.

Nat Struct Mol Biol. 2010 Nov;17(11):1324-9. doi: 10.1038/nsmb.1920. Epub 2010 Oct 10.

8.

Somatic FAS mutations are common in patients with genetically undefined autoimmune lymphoproliferative syndrome.

Dowdell KC, Niemela JE, Price S, Davis J, Hornung RL, Oliveira JB, Puck JM, Jaffe ES, Pittaluga S, Cohen JI, Fleisher TA, Rao VK.

Blood. 2010 Jun 24;115(25):5164-9. doi: 10.1182/blood-2010-01-263145. Epub 2010 Apr 1.

9.

Advances in the management and understanding of autoimmune lymphoproliferative syndrome (ALPS).

Teachey DT, Seif AE, Grupp SA.

Br J Haematol. 2010 Jan;148(2):205-16. doi: 10.1111/j.1365-2141.2009.07991.x. Epub 2009 Nov 23. Review.

10.
11.

Many checkpoints on the road to cell death: regulation of Fas-FasL interactions and Fas signaling in peripheral immune responses.

Ramaswamy M, Cleland SY, Cruz AC, Siegel RM.

Results Probl Cell Differ. 2009;49:17-47. doi: 10.1007/400_2008_24. Review.

12.

Genetic defects of apoptosis and primary immunodeficiency.

Su HC, Lenardo MJ.

Immunol Allergy Clin North Am. 2008 May;28(2):329-51, ix. doi: 10.1016/j.iac.2008.01.002. Review.

13.

Dominant inhibition of Fas ligand-mediated apoptosis due to a heterozygous mutation associated with autoimmune lymphoproliferative syndrome (ALPS) Type Ib.

Bi LL, Pan G, Atkinson TP, Zheng L, Dale JK, Makris C, Reddy V, McDonald JM, Siegel RM, Puck JM, Lenardo MJ, Straus SE.

BMC Med Genet. 2007 Jul 2;8:41.

14.

Deletion of PTEN and BMPR1A on chromosome 10q23 is not always associated with juvenile polyposis of infancy.

Salviati L, Patricelli M, Guariso G, Sturniolo GC, Alaggio R, Bernardi F, Zuffardi O, Tenconi R.

Am J Hum Genet. 2006 Sep;79(3):593-6; author reply 596-7. No abstract available.

15.

Detection, epitope-mapping and function of anti-Fas autoantibody in patients with silicosis.

Takata-Tomokuni A, Ueki A, Shiwa M, Isozaki Y, Hatayama T, Katsuyama H, Hyodoh F, Fujimoto W, Ueki H, Kusaka M, Arikuni H, Otsuki T.

Immunology. 2005 Sep;116(1):21-9.

16.

Use of GC clamps in DHPLC mutation scanning.

Wurzburger RJ, Gupta R, Parnassa AP, Jain S, Wexler JA, Chu JL, Elkon KB, Blank RD.

Clin Med Res. 2003 Apr;1(2):111-8.

17.

SPOTS: signaling protein oligomeric transduction structures are early mediators of death receptor-induced apoptosis at the plasma membrane.

Siegel RM, Muppidi JR, Sarker M, Lobito A, Jen M, Martin D, Straus SE, Lenardo MJ.

J Cell Biol. 2004 Nov 22;167(4):735-44.

18.

FAS (CD95) mutations are rare in gastric MALT lymphoma but occur more frequently in primary gastric diffuse large B-cell lymphoma.

Wohlfart S, Sebinger D, Gruber P, Buch J, Polgar D, Krupitza G, Rosner M, Hengstschläger M, Raderer M, Chott A, Müllauer L.

Am J Pathol. 2004 Mar;164(3):1081-9.

19.

Frequent deletion of Fas gene sequences encoding death and transmembrane domains in nasal natural killer/T-cell lymphoma.

Shen L, Liang AC, Lu L, Au WY, Kwong YL, Liang RH, Srivastava G.

Am J Pathol. 2002 Dec;161(6):2123-31.

Supplemental Content

Support Center